Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Neurimmune Holding

Founders Jan Grimm Roger M Nitsch

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 2
Rounds per year 0.12
Lead investments 1
Key employees Soon

Areas of investment

  • Health Care
  • Medical
  • Therapeutics
  • Biotechnology
Summary

In 2006 was created Neurimmune Holding, which is appeared as Corporate Investor. The venture was found in Europe in Switzerland. The main department of described Corporate Investor is located in the Schlieren.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Therapeutics, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight NovaGo Therapeutics.

The current fund was established by Jan Grimm, Roger M Nitsch.

The high activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.

The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are TVM Capital Life Science, Pureos Bioventures.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ambria Capital NA - Puerto Rico, Puerto Rico, United States
GreenGage Capital Illinois, United States, Wilmette
GW Asia Capital -
Nanjing Youchuang Jiaye China, Fujian, Zhangzhou
Pengpai -
Pivot Ventures -
Progression Fund -
Sixt Rental Cars Bavaria, Germany, Pullach Im Isartal
Solvay Belgium, Brussels, Brussels Hoofdstedelijk Gewest
Stanford Angels of the United Kingdom -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NovaGo Therapeutics

Biotechnology
Therapeutics
$10M04 Mar 2019 Zurich, Switzerland

AL-S Pharma

Health Care
Medical
08 Dec 2016 Zurich, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Neurimmune Holding?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 5M
Rounds per year 0.12
Peak activity year 2016
Lead investments 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

NovaGo Therapeutics

Biotechnology
Therapeutics
$10M04 Mar 2019 Zurich, Switzerland

AL-S Pharma

Health Care
Medical
08 Dec 2016 Zurich, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: